Cargando…
Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome
Perturbation of the excitation/inhibition (E/I) balance leads to neurodevelopmental diseases including to autism spectrum disorders, intellectual disability, and epilepsy. Loss-of-function mutations in the DYRK1A gene, located on human chromosome 21 (Hsa21,) lead to an intellectual disability syndro...
Autores principales: | Brault, Véronique, Nguyen, Thu Lan, Flores-Gutiérrez, Javier, Iacono, Giovanni, Birling, Marie-Christine, Lalanne, Valérie, Meziane, Hamid, Manousopoulou, Antigoni, Pavlovic, Guillaume, Lindner, Loïc, Selloum, Mohammed, Sorg, Tania, Yu, Eugene, Garbis, Spiros D., Hérault, Yann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480849/ https://www.ncbi.nlm.nih.gov/pubmed/34587162 http://dx.doi.org/10.1371/journal.pgen.1009777 |
Ejemplares similares
-
Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
por: Nguyen, Thu Lan, et al.
Publicado: (2018) -
Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome
por: Atas-Ozcan, Helin, et al.
Publicado: (2021) -
A new mouse model of ARX dup24 recapitulates the patients’ behavioral and fine motor alterations
por: Dubos, Aline, et al.
Publicado: (2018) -
Efficient and rapid generation of large genomic variants in rats and mice using CRISMERE
por: Birling, Marie-Christine, et al.
Publicado: (2017) -
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
por: Duchon, Arnaud, et al.
Publicado: (2016)